Decorin Deficiency Leads to Impaired Angiogenesis in Injured Mouse Cornea

Small leucine-rich proteoglycans play important roles in the organization of the extracellular matrix as well as for the regulation of cell behavior; two biological processes that are essential for angiogenesis. We investigated consequences of the targeted ablation of decorin (DCN), biglycan (BGN) and fibromodulin (FMOD) genes on inflammation-induced angiogenesis in the cornea. In wild-type mice, DCN was localized exclusively to the corneal stroma, while FMOD and BGN were more prominently expressed in epithelial cells. Endothelial cells from limbus blood vessels expressed BGN and FMOD, but no DCN. However, after induction of angiogenesis by chemical cauterization, DCN was expressed in the newly formed capillaries, together with BGN and FMOD. Notably, in DCN-deficient mice, the growth of vessels was significantly diminished, whereas it did not significantly change in FMOD- or BGN-deficient animals. Moreover, blood vessels of DCN-deficient mice exhibited a similar expression level of BGN as control mice, while FMOD was increased on day 3 after injury. These results indicate that DCN, in addition to its effects on fibrillogenesis, plays a regulatory role in angiogenesis and that FMOD in endothelial cells may be able to partially substitute for DCN.

[1]  T. Vogl,et al.  Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. , 2003, Trends in immunology.

[2]  R. Iozzo,et al.  In vivo selective and distant killing of cancer cells, using adenovirus‐mediated decorin gene transfer , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Jie Li,et al.  Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrix , 2003, Microscopy research and technique.

[4]  R. Iozzo,et al.  Decorin suppresses tumor cell-mediated angiogenesis , 2002, Oncogene.

[5]  A Boyde,et al.  Phenotypic Effects of Biglycan Deficiency Are Linked to Collagen Fibril Abnormalities, Are Synergized by Decorin Deficiency, and Mimic Ehlers‐Danlos‐Like Changes in Bone and Other Connective Tissues , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  R. Iozzo,et al.  Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. , 2002, The American journal of pathology.

[7]  Hans Kresse,et al.  Proteoglycans of the extracellular matrix and growth control , 2001, Journal of Cellular Physiology.

[8]  M. Comalada,et al.  Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1). , 2001, Blood.

[9]  R. Jain,et al.  Decorin inhibits endothelial migration and tube-like structure formation: role of thrombospondin-1. , 2001, Microvascular research.

[10]  R. Timpl,et al.  Biglycan and Decorin Bind Close to the N-terminal Region of the Collagen VI Triple Helix* , 2001, The Journal of Biological Chemistry.

[11]  P. Sime,et al.  Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[12]  N. Fullwood,et al.  Corneal and scleral collagens--a microscopist's perspective. , 2001, Micron.

[13]  E. Schönherr,et al.  Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co‐culture with fibroblasts and upon induction of decorin expression , 2001, Journal of cellular physiology.

[14]  T. Kuopio,et al.  Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. , 2001, The American journal of pathology.

[15]  R. Iozzo,et al.  An Anti-oncogenic Role for Decorin , 2000, The Journal of Biological Chemistry.

[16]  J. Funderburgh MINI REVIEW Keratan sulfate: structure, biosynthesis, and function , 2000 .

[17]  M. Longaker,et al.  Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. , 2000, The American journal of pathology.

[18]  George C. Sarris,et al.  Decorin Binds Near the C Terminus of Type I Collagen* , 2000, The Journal of Biological Chemistry.

[19]  M. Küchle,et al.  Immunohistochemical Localization of Vascular Endothelial Growth Factor, Transforming Growth Factor &agr;, and Transforming Growth Factor &bgr;1 in Human Corneas with Neovascularization , 2000, Cornea.

[20]  L. Svensson,et al.  Fibromodulin and lumican bind to the same region on collagen type I fibrils , 2000, FEBS letters.

[21]  N. Wulffraat,et al.  Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[22]  J. Funderburgh Keratan sulfate: structure, biosynthesis, and function. , 2000, Glycobiology.

[23]  F. Reinholt,et al.  Fibromodulin-null Mice Have Abnormal Collagen Fibrils, Tissue Organization, and Altered Lumican Deposition in Tendon* , 1999, The Journal of Biological Chemistry.

[24]  J. Schittny,et al.  Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. , 1999, European journal of cell biology.

[25]  L. Schaefer,et al.  Decorin, biglycan and their endocytosis receptor in rat renal cortex. , 1998, Kidney international.

[26]  F. Collins,et al.  Evidence for a prostate cancer susceptibility locus on the X chromosome. , 1998, Nature Genetics.

[27]  S. Goldstein,et al.  Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice , 1998, Nature Genetics.

[28]  R. Iozzo Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.

[29]  Terry Magnuson,et al.  Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican , 1998, The Journal of cell biology.

[30]  T. Shinomura,et al.  Leucine-rich repeat glycoproteins of the extracellular matrix. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[31]  R. Iozzo,et al.  Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. , 1998, The Journal of clinical investigation.

[32]  Renato V. Iozzo,et al.  Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.

[33]  R. Iozzo,et al.  The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. , 1997, Critical reviews in biochemistry and molecular biology.

[34]  I. Weber,et al.  Model Structure of Decorin and Implications for Collagen Fibrillogenesis* , 1996, The Journal of Biological Chemistry.

[35]  A. Giordano,et al.  Decorin-induced Growth Suppression Is Associated with Up-regulation of p21, an Inhibitor of Cyclin-dependent Kinases* , 1996, The Journal of Biological Chemistry.

[36]  J. Scott Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. , 1996, Biochemistry.

[37]  M. Young,et al.  Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. , 1995, Acta orthopaedica Scandinavica. Supplementum.

[38]  H Kresse,et al.  Interaction of Biglycan with Type I Collagen (*) , 1995, The Journal of Biological Chemistry.

[39]  E. Ruoslahti,et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.

[40]  Cord Sunderkötter,et al.  Macrophages and angiogenesis , 1994, Journal of leukocyte biology.

[41]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[42]  L. Sandell,et al.  Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. , 1991, The Journal of biological chemistry.

[43]  J. Roth,et al.  Cellular events associated with inflammatory angiogenesis in the mouse cornea. , 1991, The American journal of pathology.